Fact CheckerSign in

NCT02830152Active, not recruiting

Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage: A Multicenter Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 12 Jun 2024

Brief summary (registry, in English)

Intracerebral hemorrhage (ICH) in patients with non-valvular atrial fibrillation (NVAF) poses a particular dilemma for thromboprophylaxis. Left atrial appendage occlusion (LAAO) is a non-pharmacological approach to prevent cardiac embolism in NVAF. The risk-benefit ratio of LAAO in patients with NVAF after ICH is unknown. The aim of STROKECLOSE is to assess the effect of LAAO to reduce the incidence stroke, bleeding and cardiovascular mortality in patients with NVAF and prior ICH.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
750 (estimated)
First submitted
29 Jun 2016
Start date
May 2017
Primary completion date
Dec 2027
Lead sponsor
Karolinska Institutet
NCT number
NCT02830152

What you commit to

  • Study type: Interventional
  • Planned participants: 750
  • From May 2017 to the primary completion date, Dec 2027
  • 17 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior surgical LAA excision

Other

  • ICH secondary to vascular malformation or tumors
  • Estimated life expectancy of less than 1 year at eligibility assessment
  • mRS \> 3 at enrollment
  • Planned combined interventional procedures at the time of enrollment

Who the study is looking for

  • A diagnosis of paroxysmal, persistent or long-standing NVAF with CHA2DS2VASc score \>2.
  • Clinical and CT/MRI evidence of ICH within 12 months but not less than 4 weeks prior to enrollment.
  • Age \> 18 years.
  • Signed informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (17)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University Hospital
Coordinator of this site? Confirm its status
AarhusDenmarkUnknown status
Bispebjerg University Hospital
Coordinator of this site? Confirm its status
BispebjergDenmarkUnknown status
Rikshospitalet Glostrup
Coordinator of this site? Confirm its status
Glostrup MunicipalityDenmarkUnknown status
Herlev sjukhus
Coordinator of this site? Confirm its status
HerlevDenmarkUnknown status
Odenses Universitetssjukhus
Coordinator of this site? Confirm its status
OdenseDenmarkUnknown status
Helsinki University Hospital
Coordinator of this site? Confirm its status
HelsinkiFinlandUnknown status
North Karelia Central Hospital
Coordinator of this site? Confirm its status
JoensuuFinlandUnknown status
Kuopio University Hospital
Coordinator of this site? Confirm its status
KuopioFinlandUnknown status
Turku University Hospital
Coordinator of this site? Confirm its status
TurkuFinlandUnknown status
Vaasa Centralsjukhus
Coordinator of this site? Confirm its status
VaasaFinlandUnknown status
Haukeland Universitetssjukhus
Coordinator of this site? Confirm its status
BergenNorwayUnknown status
Oslo University Hospital
Coordinator of this site? Confirm its status
OsloNorwayUnknown status
Sahlgrenska University Hospital
Coordinator of this site? Confirm its status
GothenburgSwedenUnknown status
Universitetssjukhuset Skåne
Coordinator of this site? Confirm its status
LundSwedenUnknown status
Universitetssjukhuset
Coordinator of this site? Confirm its status
ÖrebroSwedenUnknown status
Danderyd Hospital
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status
Akademiska sjukhuset
Coordinator of this site? Confirm its status
UppsalaSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.